Early erythropoietin therapy attenuates remodeling and preserves function of left ventricle in porcine myocardial infarction

Journal of Investigative Medicine

Volumn 59, Issue 3, 2011, Pages 574-586

  Chua, Sarah ^a   Leu, Steve ^a   Lin, Yu Chun ^a   Sheu, Jiunn Jye ^a   Sun, Cheuk Kwan ^a   Chung, Sheng Ying ^a   Chai, Han Tan ^a   Lee, Fan Yen ^a   Kao, Ying Hsien ^b   Wu, Chiung Jen ^a   Chang, Li Teh ^c   Ko, Sheung Fat ^a   Yip, Hon Kan ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b I SHOU UNIVERSITY   (Taiwan)

^c MEIHO UNIVERSITY   (Taiwan)

Author keywords

Acute myocardial infarction; Apoptosis; Erythropoietin; Inflammation; Mini pig model; Mitochondrial damage

Indexed keywords

CASPASE 3; CD31 ANTIGEN; CD40 ANTIGEN; CELL SURFACE MARKER; CONNEXIN 43; CYTOCHROME C; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GELATINASE B; INTERLEUKIN 8; MESSENGER RNA; MITOCHONDRIAL ENZYME; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN BCL 2; PROTEIN KINASE C EPSILON; RECOMBINANT ERYTHROPOIETIN; THY 1 ANTIGEN; VON WILLEBRAND FACTOR;

ACUTE HEART INFARCTION; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW BIOPSY; CAPILLARY DENSITY; CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DRUG EFFECT; DRUG MECHANISM; EARLY INTERVENTION; ECHOCARDIOGRAPHY; GENE EXPRESSION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE PERFORMANCE; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HISTOPATHOLOGY; INFLAMMATION; MALE; MINIPIG; MONONUCLEAR CELL; NONHUMAN; OXIDATIVE STRESS; PERIPHERAL BLOOD STEM CELL; PROTEIN EXPRESSION; REPEATED DRUG DOSE;

ANIMALIA; SUIDAE; SUS;

ANIMALS; DISEASE MODELS, ANIMAL; ERYTHROPOIETIN; HUMANS; MALE; MYOCARDIAL INFARCTION; RECOMBINANT PROTEINS; SWINE; SWINE, MINIATURE; TIME FACTORS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 79960097190     PISSN: 17088267     EISSN: 17088267     Source Type: Journal    
DOI: 10.2310/JIM.0b013e31820877dc     Document Type: Article

References (34)

1. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res. 2002;53:31-47. (Pubitemid 34020764)
2. Lambert JM, Lopez EF, Lindsey ML. Macrophage roles following myocardial infarction. Int J Cardiol. 2008;130:147-158.
3. Frangogiannis NG. The immune system and cardiac repair. Pharmacol Res. 2008;58:88-111.
4. De Scheerder I, Vanderkerckhove J, Robbrecht J, et al. Post cardiac injury syndrome and an increased humoral immune response against the major contractile proteins (actin and myosin). Am J Cardiol. 1985;56:631-633. (Pubitemid 16203688)
5. Lange LG, Schreiner GF. Immune mechanisms of cardiac disease. New Engl J Med. 1994;330:1129-1135. (Pubitemid 24118272)
6. Testa M, Yeh M, Lee P. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol. 1996;28:964-971. (Pubitemid 26348163)
7. Torre-Amione G, Kapadia S, Benedict C, et al. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol. 1996;27:1201-1206. (Pubitemid 26117714)
8. Ono K, Matsumori A, Shioi T, et al. Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling. Circulation. 1998;98:149-156. (Pubitemid 28317895)
9. Kinugawa S, Tsutsui H, Hayashidani S, et al. Treatment with dimethylthiourea prevents left ventricular remodeling and failure after experimental myocardial infarction in mice: role of oxidative stress. Circ Res. 2000;87:392-398.
10. Kumar D, Lou H, Singal PK. Oxidative stress and apoptosis in heart dysfunction. Herz. 2002;27:662-668. (Pubitemid 35415251)
11. Tramontano AF, Muniyappa R, Black AD, et al. Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt dependent pathway. Biochem Biophys Res Commun. 2003;308:990-994. (Pubitemid 36976556)
12. Calvillo L, Latini R, Kajstura J, et al. Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci U S A. 2003;100:802-806.
13. Moon C, Krawzyck M, Ahn D, et al. Erythropoietin reduces myocardial infarction and left ventricular function decline after coronary artery ligation in rats. Proc Natl Acad Sci U S A. 2003;100:11612-11617. (Pubitemid 37205984)
14. Hirata A, Minamino T, Asanuma H, et al. Erythropoietin enhances neovascularization of ischemic myocardium and improves left ventricular dysfunction after myocardial infarction in dogs. J Am Coll Cardiol. 2006;48:176-184. (Pubitemid 43929217)
15. van der Meer P, Voors AA, Lipsic E, et al. Erythropoietin in cardiovascular diseases. Eur Heart J. 2004;44:63-67.
16. Lipsic E, Van der Meer P, Henning RH, et al. Timing of erythropoietin treatment for cardioprotection in ischemia/reperfusion. J Cardiovasc Pharmacol. 2004;44:473-479. (Pubitemid 39305089)
17. Lin JS, Chen YS, Chiang HS, et al. Hypoxic preconditioning protects rat hearts against ischemiaYreperfusion injury: role of erythropoietin on progenitor cell mobilization. J Physiol. 2008;586:5757-5769.
18. Brines ML, Ghezzi P, Keenan S, et al. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci U S A. 2000;97:10526-10531.
19. Villa P, Bigini P, Mennini T, et al. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med. 2003;198:971-975. (Pubitemid 37152934)
20. Digicaylioglu M, Lipton SA. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappa B signalling cascades. Nature. 2001;412:641-647. (Pubitemid 32772276)
21. Kawakami M, Sekiguchi M, Sato K, et al. Erythropoietin receptor-mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia. J Biol Chem. 2001;276:39469-39475.
22. Carsten Schneider C, Jaquet K, Malisius R, et al. Attenuation of cardiac remodelling by endocardial injection of erythropoietin: ultrasonic strain-rate imaging in a model of hibernating myocardium. Eur Heart J. 2007;28:499-509. (Pubitemid 47343555)
23. Toma C, Letts DP, Tanabe M, et al. Positive effect of darbepoetin on peri-infarction remodeling in a porcine model of myocardial ischemia- reperfusion. J Mol Cell Cardiol. 2007;43:130-136. (Pubitemid 47069386)
24. Sun CK, Chang LT, Sheu JJ, et al. Bone marrowYderived mononuclear cell therapy alleviates left ventricular remodeling and improves heart function in rat dilated cardiomyopathy. Crit Care Med. 2009;37:1197-1205.
25. Boengler K, Dodoni G, Rodriguez-Sinovas A, et al. Connexin 43 in cardiomyocyte mitochondria and its increase by ischemic preconditioning. Cardiovasc Res. 2005;67:234-244. (Pubitemid 40943616)
26. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res. 2002;53:31-47. (Pubitemid 34020764)
27. Varda-Bloom N, Leor J, Ohad DG, et al. Cytotoxic T lymphocytes are activated following myocardial infarction and can recognize and kill healthy myocytes in vitro. J Mol Cell Cardiol. 2000;32:2141-2149. (Pubitemid 32039766)
28. Chien KR. Stress pathways and heart failure. Cell. 1999;98:555-558. (Pubitemid 29418947)
29. Wojchowski DM, Gregory RC, Miller CP, et al. Signal transduction in the erythropoietin receptor system. Exp Cell Res. 1999;253:143-156.
30. Tramontano AF, Muniyappa R, Black AD, et al. Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway. Biochem Biophys Res Commun. 2003;308:990-994. (Pubitemid 36976556)
31. Parsa CJ, Matsumoto A, Kim J, et al. A novel protective effect of erythropoietin in the infarcted heart. J Clin Invest. 2003;112:999-1007. (Pubitemid 38056315)
32. Yip HK, Chang LT, Wu CJ, et al. Autologous bone marrowYderived mesenchymal stem cell therapy prevents the damage of viable myocardium and improves rat heart function following acute anterior myocardial infarction. Circ J. 2008;72:1336-1345.
33. Garnier A, Fortin D, Deloménie C, et al. Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. J Physiol. 2003;551:491-501. (Pubitemid 37121707)
34. Suwa M, Nakano H, Kumagai S. Effects of chronic AICAR treatment on fiber composition, enzyme activity, UCP3, and PGC-1 in rat muscles. J Appl Physiol. 2003;95:960-968. (Pubitemid 37033988)